Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ikuko Sakamoto"'
Publikováno v:
BMC Surgery, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background Pelvic organ prolapse (POP) is greatly affecting the quality of life (QOL) of women. There are some surgical techniques for POP repair, for example, transvaginal mesh surgery (TVM), laparoscopic sacrocolpopexy (LSC), and robot-ass
Externí odkaz:
https://doaj.org/article/46e6b852ebef4b7c8ee565950c82fb3c
Publikováno v:
Gynecology and Minimally Invasive Therapy, Vol 6, Iss 3, Pp 113-115 (2017)
Objective: To evaluate the risk of spilling cancer cells during total laparoscopic hysterectomy (TLH) using a uterine manipulator in early-stage endometrial cancer patients. Materials and methods: We conducted a prospective study among women undergoi
Externí odkaz:
https://doaj.org/article/2263cb3b780e4933985178f5d45514ea
Autor:
Yosuke Hirotsu, Udo Schmidt-Edelkraut, Hiroshi Nakagomi, Ikuko Sakamoto, Markus Hartenfeller, Ram Narang, Theodoros G. Soldatos, Sajo Kaduthanam, Xiaoyue Wang, Stephan Hettich, Stephan Brock, David B. Jackson, Masao Omata
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 11, p 3895 (2020)
BRCA1/2 variants are prognostic biomarkers for hereditary breast and/or ovarian cancer (HBOC) syndrome and predictive biomarkers for PARP inhibition. In this study, we benchmarked the classification of BRCA1/2 variants from patients with HBOC-related
Externí odkaz:
https://doaj.org/article/29e95b05783847f89bbb1d6694f55d32
Autor:
Takahiro Nozaki1 nozaki-bcwc@ych.pref.yamanashi.jp, Ikuko Sakamoto1, Keiko Kagami1, Kenji Amemiya2, Yosuke Hirotsu2, Hitoshi Mochizuki2, Masao Omata2
Publikováno v:
Journal of Gynecologic Oncology. Jul2024, Vol. 35 Issue 4, p1-12. 12p.
Autor:
Ikuko Sakamoto1,2 I-nagata@ych.pref.yamanashi.jp, Yosuke Hirotsu2, Kenji Amemiya2,3, Takahiro Nozaki1, Hitoshi Mochizuki2, Masao Omata2,4
Publikováno v:
Journal of Gynecologic Oncology. Jan2023, Vol. 34 Issue 1, p1-12. 12p.
Autor:
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Publikováno v:
Cancer Cytopathology. 130:640-649
The objective of this study was to identify the clinical utility of genomic analysis of ascitic fluid cytology (AC) in patients with epithelial ovarian cancer.Targeted next-generation sequencing was used to analyze 66 samples from 33 patients who had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01fecdc08b671217de27bfbf2d3ff712
https://doi.org/10.1002/cncy.22596
https://doi.org/10.1002/cncy.22596
Autor:
Ikuko Sakamoto, Keiko Kagami, Takahiro Nozaki, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Masao Omata
Publikováno v:
American Journal of Surgical Pathology; Oct2023, Vol. 47 Issue 10, p1144-1150, 7p
Autor:
Ikuko Sakamoto, Yosuke Hirotsu, Kenji Amemiya, Takahiro Nozaki, Hitoshi Mochizuki, Masao Omata
Publikováno v:
Journal of gynecologic oncology. 34(1)
Elucidation of clonal origin of synchronous endometrial and ovarian cancers (SEOs).We reviewed 852 patients who diagnosed endometrial and/or ovarian cancer. Forty-five (5.3%) patients were diagnosed as SEOs. We evaluated blood and tissue samples from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcd21b3463bb2dba8a4c9d50bb0e3ab5
https://pubmed.ncbi.nlm.nih.gov/36245225
https://pubmed.ncbi.nlm.nih.gov/36245225
Autor:
Atsushi Ikegami, Hiroshi Nakagomi, Masao Omata, Katsuhiro Teramoto, Yosuke Hirotsu, Ikuko Sakamoto
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 45:743-747
Brain metastases (BM) from epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC) are extremely rare, accounting for 1-2.5% of all cases. Although therapeutic options, such as surgery, irradiation and chemotherapy are proven to yield surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78880f988334df61aea8b426bd6bf567
https://doi.org/10.1111/jog.13851
https://doi.org/10.1111/jog.13851
Autor:
Ikuko Sakamoto, Satoko Nakagomi, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata, Yosuke Hirotsu, Hiroshi Nakagomi, Masayuki Inoue, Takeo Kubota
Publikováno v:
Cancer Science
Utility of combined annotation-dependent depletion (CADD) score was recently reported to rank pathogenicity as C-scores ranging 1-99 for both confirmed deleterious mutation. Using C-scores for BRCA1/2 variants, we tried to constitute the classificati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a42cccacbd4af163b65d2d6e897d485
http://europepmc.org/articles/PMC5797818
http://europepmc.org/articles/PMC5797818